Yu, GeRice, StephenHeer, RakeshLewis, RebeccaVadiveloo, ThenmalarMariappan, ParamananthanPenegar, StevenClark, EmmaTandogdu, ZaferHall, EmmaVale, Luke2023-06-132023-06-132023-07Yu, G, Rice, S, Heer, R, Lewis, R, Vadiveloo, T, Mariappan, P, Penegar, S, Clark, E, Tandogdu, Z, Hall, E & Vale, L 2023, 'Photodynamic Diagnosis-guided Transurethral Resection of Bladder Tumour in Participants with a First Suspected Diagnosis of Intermediate- or High-risk Non–muscle-invasive Bladder Cancer : Cost-effectiveness Analysis Alongside a Randomised Controlled Trial', European Urology Open Science, vol. 53, pp. 67-77. https://doi.org/10.1016/j.euros.2023.05.0032666-1691https://hdl.handle.net/2164/20844Funding/Support and role of the sponsor: The article processing charge was funded by the PHOTO project, which was funded by the National Institute for Health and Care Research (NIHR) Health Technology Assessment programme (11/142/02). The views expressed are those of the authors and not necessarily those of the NIHR or the Department of Health and Social Care. The funding body had no direct role in the study. Acknowledgments: This study is part of the PHOTO project. We thank the PHOTO team who contributed to the overall research project and are grateful to all the participants and facility staff who took part in the study.11693728engSDG 3 - Good Health and Well-beingCost effectivenessHexvixNon–muscle-invasive bladder cancerPhotodynamic diagnosisRandomised trialSurgeryTransurethral resection of bladder tumourUrinary bladder neoplasmsR MedicineUrologyNational Institute for Health Research (NIHR)11/142/02Supplementary InformationRPhotodynamic Diagnosis-guided Transurethral Resection of Bladder Tumour in Participants with a First Suspected Diagnosis of Intermediate- or High-risk Non–muscle-invasive Bladder Cancer : Cost-effectiveness Analysis Alongside a Randomised Controlled TrialJournal article10.1016/j.euros.2023.05.003https://www.scopus.com/pages/publications/85160599917